Retinal Registry

Medtech · Private

Tablet-based software tool for glaucoma detection using novel visual field test analysis and retinal nerve fiber mapping

Updated

Sector
Medtech
Total capital
$276K
Grants
$276K
1 award
At sector median 1 award
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median 2 patents

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history, newest first
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: A Pair of Linked Cartographic Maps of our Brain Derived from Clinical Glaucoma Data$276,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2282EARLY ALZHEIMER'S DIAGNOSTICS LLC——
2283Articulate Biosciences, LLC——
2284CAMERAD TECHNOLOGIES, LLC——
2285Retinal Registry——
2286Resolution Bioscience——
2287iAssay, Inc.——
2288CRYOSCOPE MEDICAL——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

No people are linked to this company yet.

People appear here when they are named as related persons in the company's own Form D filings. We don't infer people from social profiles.

Checked: SEC EDGAR Form D related persons through

Patents

No patents are on record under this company's name.

USPTO publishes applications about 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won't match.

Checked: USPTO granted patents and published applications

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.